Rockwell Medical, Inc. (NASDAQ:RMTI – Get Rating) saw a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 242,400 shares, a decline of 40.6% from the May 15th total of 408,100 shares. Approximately 3.1% of the company’s stock are sold short. Based on an average […]
Rockwell Medical (NASDAQ:RMTI – Get Rating) and Prothena (NASDAQ:PRTA – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, risk, profitability, analyst recommendations and dividends. Insider & Institutional Ownership 27.9% of Rockwell Medical shares are […]
Rockwell Medical (NASDAQ:RMTI – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other […]
Rockwell Medical, Inc. (NASDAQ:RMTI – Get Rating) was the recipient of a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 408,100 shares, a decline of 79.2% from the April 30th total of 1,960,000 shares. Approximately 5.7% of the shares of the company are sold […]
Rockwell Medical (NASDAQ:RMTI – Get Rating) issued its earnings results on Thursday. The company reported ($0.84) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.99) by $0.15, MarketWatch Earnings reports. Rockwell Medical had a negative net margin of 51.27% and a negative return on equity of 302.38%. During the same period […]